The dangerous cocktail of substandard drugs and poor regulatory oversight in India

The dangerous cocktail of substandard drugs and poor regulatory oversight in India WHO estimates that one in ten medical products in low-and-middle-income countries is substandard or falsified. This includes India

No comments:

Post a Comment